Access cutting-edge lymphoproliferative disorder treatment through this clinical trial at a research site in Albert Lea. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Albert Lea location
Preparing your pre-screening questions…
Access lymphoproliferative disorder specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lymphoproliferative disorder treatment provided free
Check if you qualify for this lymphoproliferative disorder clinical trial in Albert Lea, MN
No-Cost Study Care
Local to Albert Lea
Convenient for MN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This clinical trial evaluates the impact of preexisting and therapy-emergent germline and somatic variants on cytopenia in patients with multiple myeloma or CD19 positive lymphoproliferative disorder (LPD) following chimeric antigen receptor T-cell (CAR-T) therapy. The most common adverse event after CAR-T therapy is lower than normal blood cells (cytopenia) and up to one third of patients experience cytopenia that last longer than 30 days post-infusion. Germline and somatic variants are changes in genes found using cancer genomic tests. Cancer genetic/genomic testing is a series of tests that find specific changes in cancer cells or in blood deoxyribonucleic acid. Identifying gene mutations may help identify the risk of cytopenia in patients with multiple myeloma or CD19 positive LPD following CAR-T therapy.
Sponsor: Mayo Clinic
Yes, this clinical trial (NCT06630104) has an active research site in Albert Lea, MN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for lymphoproliferative disorder treatment options in Albert Lea, MN, this clinical trial (NCT06630104) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Albert Lea research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lymphoproliferative disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all lymphoproliferative disorder clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Albert Lea — not just this study.
Browse Rheumatoid Arthritis Trials in Albert Lea →